Nicholas Wilcken

4.0k total citations
27 papers, 658 citations indexed

About

Nicholas Wilcken is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nicholas Wilcken has authored 27 papers receiving a total of 658 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 10 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nicholas Wilcken's work include Cancer Treatment and Pharmacology (14 papers), Breast Cancer Treatment Studies (10 papers) and Advanced Breast Cancer Therapies (5 papers). Nicholas Wilcken is often cited by papers focused on Cancer Treatment and Pharmacology (14 papers), Breast Cancer Treatment Studies (10 papers) and Advanced Breast Cancer Therapies (5 papers). Nicholas Wilcken collaborates with scholars based in Australia, United Kingdom and Denmark. Nicholas Wilcken's co-authors include Davina Ghersi, John Simes, Annabel Goodwin, Melina L Willson, Sharon Parker, R. J. Simes, Emma Donoghue, Sue Carrick, Charlene Thornton and Sharon K. Parker and has published in prestigious journals such as Journal of Clinical Oncology, Cochrane Database of Systematic Reviews and British Journal of Cancer.

In The Last Decade

Nicholas Wilcken

26 papers receiving 640 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicholas Wilcken Australia 14 463 307 155 90 89 27 658
N. Malamos Greece 15 649 1.4× 343 1.1× 212 1.4× 54 0.6× 138 1.6× 32 864
Winfried Schoenegg Germany 13 354 0.8× 242 0.8× 194 1.3× 54 0.6× 206 2.3× 24 636
M Gerstenhauer Germany 7 262 0.6× 259 0.8× 93 0.6× 108 1.2× 122 1.4× 7 609
健二郎 青儀 2 404 0.9× 354 1.2× 87 0.6× 98 1.1× 83 0.9× 2 581
A. Goldhirsch Italy 15 537 1.2× 382 1.2× 143 0.9× 123 1.4× 135 1.5× 39 825
Claudia Omarini Italy 14 507 1.1× 267 0.9× 243 1.6× 73 0.8× 184 2.1× 54 777
A. Vindevoghel Belgium 10 647 1.4× 474 1.5× 88 0.6× 118 1.3× 134 1.5× 23 868
V. Guillem Porta Spain 9 474 1.0× 196 0.6× 116 0.7× 62 0.7× 251 2.8× 16 647
Laurence J. van Warmerdam Netherlands 9 563 1.2× 238 0.8× 116 0.7× 68 0.8× 150 1.7× 11 713
Fernando Lara-Medina Mexico 17 487 1.1× 411 1.3× 198 1.3× 145 1.6× 201 2.3× 40 906

Countries citing papers authored by Nicholas Wilcken

Since Specialization
Citations

This map shows the geographic impact of Nicholas Wilcken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas Wilcken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas Wilcken more than expected).

Fields of papers citing papers by Nicholas Wilcken

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas Wilcken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas Wilcken. The network helps show where Nicholas Wilcken may publish in the future.

Co-authorship network of co-authors of Nicholas Wilcken

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas Wilcken. A scholar is included among the top collaborators of Nicholas Wilcken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas Wilcken. Nicholas Wilcken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mileshkin, Linda, Dariush Etemadmoghadam, Richard W. Tothill, et al.. (2019). Clinical impact of tissue of origin testing and mutation profiling in the Solving Unknown Primary Cancer (SUPER) national prospective study: Experience of the first two years.. Journal of Clinical Oncology. 37(15_suppl). 3072–3072. 4 indexed citations
2.
Gebski, Val, James Wei Tatt Toh, Nimalan Pathma‐Nathan, et al.. (2019). Outcomes of younger patients diagnosed with locally advanced rectal cancer.. Journal of Clinical Oncology. 37(4_suppl). 500–500. 2 indexed citations
3.
Egger, Sam, Melina L Willson, Jenna Morgan, et al.. (2017). Platinum-containing regimens for metastatic breast cancer. Cochrane Database of Systematic Reviews. 2017(8). CD003374–CD003374. 46 indexed citations
4.
5.
McCarthy, Nicole, Frances Boyle, Nicholas Zdenkowski, et al.. (2014). Neoadjuvant chemotherapy with sequential anthracycline–docetaxel with gemcitabine for large operable or locally advanced breast cancer: ANZ 0502 (NeoGem). The Breast. 23(2). 142–151. 5 indexed citations
6.
Goodwin, Annabel, Sharon Parker, Davina Ghersi, & Nicholas Wilcken. (2013). Post-operative radiotherapy for ductal carcinoma in situ of the breast. Cochrane Database of Systematic Reviews. 2013(11). 40 indexed citations
7.
Carus, Andreas, Howard Gurney, Val Gebski, et al.. (2013). Impact of baseline and nadir neutrophil index in non-small cell lung cancer and ovarian cancer patients: Assessment of chemotherapy for resolution of unfavourable neutrophilia. Journal of Translational Medicine. 11(1). 189–189. 21 indexed citations
8.
Yee, Jasmine, Glen M. Davis, Jane Beith, et al.. (2013). Physical activity and fitness in women with metastatic breast cancer.. Journal of Clinical Oncology. 31(26_suppl). 136–136. 2 indexed citations
9.
Lord, Sarah J., M. Luke Marinovich, Jillian A. Patterson, et al.. (2012). Incidence of metastatic breast cancer in an Australian population‐based cohort of women with non‐metastatic breast cancer at diagnosis. The Medical Journal of Australia. 196(11). 688–692. 34 indexed citations
10.
Carus, Andreas, Frede Donskov, Val Gebski, et al.. (2011). Toxicity-adjusted dose (TAD) administration of chemotherapy: Effect of baseline and nadir neutrophil count in patients with breast, ovarian, and lung cancer?. Journal of Clinical Oncology. 29(15_suppl). e21023–e21023. 1 indexed citations
11.
Webber, Kate, David Goldstein, Barbara Bennett, et al.. (2010). Influence of fatigue after breast cancer adjuvant therapy on health care utilization and perceived needs.. Journal of Clinical Oncology. 28(15_suppl). 9047–9047.
12.
Goodwin, Annabel, Sharon Parker, Davina Ghersi, & Nicholas Wilcken. (2009). Post-operative radiotherapy for ductal carcinoma in situ of the breast. Cochrane Database of Systematic Reviews. CD000563–CD000563. 70 indexed citations
13.
Gennari, Alessandra, Maria Pia Sormani, Paolo Bruzzi, et al.. (2008). A meta-analysis of chemotherapy duration in metastatic breast cancer (MBC). Journal of Clinical Oncology. 26(15_suppl). 1067–1067. 8 indexed citations
14.
Goldstein, D., Barbara Bennett, Blake Cameron, et al.. (2008). A prospective cohort study of fatigue after adjuvant therapy for breast cancer: Association with hematologic, endocrine, and immune parameters. Journal of Clinical Oncology. 26(15_suppl). 9596–9596. 1 indexed citations
15.
Carrick, Sue, Sharon K. Parker, Charlene Thornton, et al.. (2005). Single agent versus combination chemotherapy for metastatic breast cancer. Cochrane Database of Systematic Reviews. CD003372–CD003372. 85 indexed citations
16.
Duric, V., Martin R. Stockler, PN Butow, et al.. (2005). Comparing patients’ and their partners’ preferences for adjuvant chemotherapy (ACT) in early breast cancer (EBC). Journal of Clinical Oncology. 23(16_suppl). 6074–6074. 2 indexed citations
17.
Ghersi, Davina, Nicholas Wilcken, & R. J. Simes. (2005). A systematic review of taxane-containing regimens for metastatic breast cancer. British Journal of Cancer. 93(3). 293–301. 75 indexed citations
18.
Lord, Sarah J., Davina Ghersi, Melina Gattellari, et al.. (2004). Antitumour antibiotic containing regimens for metastatic breast cancer. Cochrane Database of Systematic Reviews. 2021(2). CD003367–CD003367. 20 indexed citations
19.
Ghersi, Davina, Nicholas Wilcken, John Simes, & Emma Donoghue. (2003). Taxane containing regimens for metastatic breast cancer. The Cochrane Database of Systematic Reviews. CD003366–CD003366. 35 indexed citations
20.
Stockler, Martin R., Nicholas Wilcken, & Alan S. Coates. (2003). Chemotherapy for Advanced Breast Cancer – How Long Should it Continue?. Breast Cancer Research and Treatment. 81(S1). 49–52. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by N. Malamos Breakdown of academic impact, for papers by Winfried Schoenegg Breakdown of academic impact, for papers by M Gerstenhauer Breakdown of academic impact, for papers by 健二郎 青儀 Breakdown of academic impact, for papers by A. Goldhirsch Breakdown of academic impact, for papers by Claudia Omarini Breakdown of academic impact, for papers by A. Vindevoghel Breakdown of academic impact, for papers by V. Guillem Porta Breakdown of academic impact, for papers by Laurence J. van Warmerdam Breakdown of academic impact, for papers by Fernando Lara-Medina
Rankless by CCL
2026